Why it matters: PPIs are used to reduce acid levels in the stomach, in order to treat conditions such as gastro-oesphogeal reflux disease. NICE guidance recommends that the lowest dose is used to treat the symptoms. Although PPIs are safe drugs, their use has been associated with an increase in a number of disorders, including Clostridium difficile infection and a higher risk of community-aquired pneunmonia. The doses of PPIs are defined in the NICE guidance.
Description: Prescribing of higher dose Proton Prump Inhibitors compared with prescribing of all PPIs (excluding liquids)
CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.